Showing results (321-330 of 855) with videos related to
Sort By:
Pageof 86
Current Hematologic Malignancy Reports|February 29, 2020
Is There a Role for Chemotherapy in the Era of Targeted Therapies?Jason C Lee, Nicole LamannaCurrent Hematologic Malignancy Reports|November 29, 2019
Health-Related Quality of Life and Treatment of Older Adults with Acute Myeloid Leukemia: a Young International Society of Geriatric Oncology Review PaperKah Poh Loh, Maya Abdallah, Anita J Kumar, et al.Current Hematologic Malignancy Reports|February 17, 2020
Advances in the Diagnosis and Treatment of Large Granular Lymphocytic LeukemiaHeeJin Cheon, Karolina H Dziewulska, Katharine B Moosic, et al.Current Hematologic Malignancy Reports|January 23, 2019
Industry's Giant Leap Into Cellular Therapy: Catalyzing Chimeric Antigen Receptor T Cell (CAR-T) ImmunotherapyStacie Ittershagen, Solveig Ericson, Lamis Eldjerou, et al.Current Hematologic Malignancy Reports|January 26, 2020
Moving Past Ganciclovir and Foscarnet: Advances in CMV TherapyMorgan HakkiCurrent Hematologic Malignancy Reports|July 11, 2025
Highlights from MPN Asia 2025: Advances in Molecular Pathogenesis and Therapeutic Strategies in Myeloproliferative NeoplasmsPrithviraj Bose, Zhijian Xiao, Hans C Hasselbalch, et al.Current Hematologic Malignancy Reports|September 13, 2013
New insights and modern treatment of AL amyloidosisChakra P Chaulagain, Raymond L ComenzoCurrent Hematologic Malignancy Reports|August 15, 2014
Antiplatelet therapy in the management of myeloproliferative neoplasmsAlberto Alvarez-Larrán, Carlos BessesCurrent Hematologic Malignancy Reports|May 14, 2013
High-dose cytarabine (HD araC) in the treatment of leukemias: a reviewNicholas D Reese, Gary J SchillerCurrent Hematologic Malignancy Reports|April 9, 2013
Is minimal residual disease monitoring clinically relevant in adults with acute myelogenous leukemia?Karen-Sue B Carlson, Monica L GuzmanPageof 86